stock market investment discussion forums
  Login  |  Register |  Site Map  |  Blogs |  Recent Activity  |  Members  | Glossary
Ticker/Industry
  Joined Today: 0

New Member Registration | Post New Message | Invite Friends | 
Jump to #

View All KERX Posts | Show Members
KERX Home KERX Profile SEC Filings Search Results
#13: TheMachine:  KERX The upside could be massive
What am I missing here?This stock could be trading a lot higher soon.  What...
June 2, 2009
12:59:47 PM
#12: TheMachine:  KERX Stock News : Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
KRX-0401 + Capecitabine More Than Doubles Time to Progression and Overall...
June 2, 2009
06:25:39 AM
#11: TheMachine:  KERX Stock News : Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology
Results Will be Reported from Phase 2 Studies Evaluating KRX-0401 in...
May 28, 2009
04:01:58 AM
#10: TheMachine:  Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
Plan to Include Refocusing of Operations and Workforce...
April 14, 2008
12:18:24 AM
#9: TheMachine:  Keryx Biopharmaceuticals to Present at JPMorgan Healthcare Conference
NEW YORK, Jan. 3 /PRNewswire-FirstCall/ -- Keryx...
January 18, 2008
05:28:11 PM
#8: FastFun:  Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
  Dr. Paul Richardson presents Phase 1 results demonstrating clinical...
December 16, 2007
06:50:50 PM
#7: FastFun:  DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
  'Room Temp' Technology Builds on Consumer Appeal and Tactical Importance...
December 16, 2007
06:50:05 PM
#6: FastFun:  Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
  Data on Perifosine in the Treatment of Patients with Relapsed/Refractory...
December 7, 2007
07:09:11 PM
#5: FastFun:  Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
  No Safety Concerns Raised Sulodexide Phase 3 study to continue without...
December 7, 2007
07:04:08 PM
#4: FastFun:  Re: Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
I wonder if this is "fast tracked" .  I hope it passes the FDA ASAP
November 30, 2007
11:41:49 AM
#3: FastFun:  Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
  Oral Presentation by Dr. Robert Figlin Highlights Phase 2 Data Showing...
November 26, 2007
08:34:21 PM
#2: FastFun:  Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
  Deal Includes up to $100MM in License Fees and Potential Milestone...
October 15, 2007
11:54:18 PM
#1: Jason:  KERX, Keryx Biopharmaceuticals to Present at The Bank of America 2007 Health Care Conference
Presentation Scheduled for Wednesday, May 30th at 11:20am PT Keryx...
June 3, 2007
08:53:23 PM

 


Tips for using stock message boards discussion forums

Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use.
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.